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http://intl.elsevierhealth.com/journals/ijidLETTERS TO THE EDITORThe toxicity of essential oils
Rasooli et al. have reported the anti-listerial effects of thyme
oil.1 The authors state that ‘‘essential oils such as thyme oils
(. . .) could be considered as preservative materials on some
kinds of foods (. . .) they could find an application as additives
to foodstuffs (. . .)’’. Essential oils, including those from
different species of thyme, have a variable composition of
components, some of which are acutely toxic to humans in
small amounts. Eugenol, which is a component of thyme oil
from Thymus capitatus, cilicus, funkii, and vulgaris, is hepa-
totoxic.2,3 In children, as little as 10 ml of eugenol-containing
clove oil has led to near fatal hepatic failure.4 Other toxic
effects of essential oils include mucosal irritation, vomiting,
epigastric pain, diarrhea, convulsions, renal failure,5 and
central nervous system depression.6 Chronic toxicity has also
been described: terpineol, which is a component of thyme oil
from Thymus eriocalyx, is mutagenic in the Salmonella/
microsomal assay (Ames test).7 Linalool, which is a compo-
nent of oil from the same Thymus species, has been shown to
be cytotoxic to human skin cells.8
Essential oils, including thyme oil, can therefore not be
recommended for use in food preservation. Like any artificial
food additive, every component would need to be tested
rigorously for toxicity before its contact with food for human
consumption could be permitted.
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I appreciate Dr Eisenhut’s concerns; however, I believe that he
has neglected the issue of dose dependency in antimicrobial
agents. It is well established that any chemical agent, includ-
ing essential oils or commercially available antibiotics used in
combating infectious diseases,may exert adverse effects. The
antimicrobial doses suggestedbyus inour paperarewell belowthe doses referred to by Dr Eisenhut. For example, reference 2
cited by Dr Eisenhut regarding the hepatotoxicity of clove oil
describes ‘‘a 15-month-old boy who developed fulminant
hepatic failure after ingesting 10 ml of clove oil’’. Please note
that 10 ml of clove oil is certainly toxic not only to a 15-month-
old baby but also to any adult. Reference 7 citedbyDr Eisenhut
states: ‘‘In all cases, the upper limit of the dose interval tested
was either the highest non-toxic dose or the lowest dose of thePublished by Elsevier Ltd. All rights reserved.
366 Letters to the Editormonoterpene toxic to TA100 strain in the preliminary toxicity
test. No mutagenic effect was found with () camphor, citral,
citronellal, 1,8-cineole, and ()-menthol. Terpineol caused a
slight but dose-related increase in the number of his+ rever-
tants with TA102 tester strain both without and with addition
of S9 mixture. The results from this study therefore suggest
that, with the exception of terpineol, the monoterpenoid
compounds tested are not mutagenic in the Ames test’’. Thus
not all the essential oil compounds are mutagenic.
The antifungal activity of the essential oils of Thymus on
Candida spp has been described as warranting future ther-
apeutic trials on mucocutaneous candidosis (Pina-Vaz
et al.1). Paster and co-workers2 applied essential oils from
thyme for 24 hours against the mycelia and spores of Asper-
gillus flavus, Aspergillus niger, and Aspergillus ochraceus, as
well as against the natural microflora of wheat grains. The
thyme essential oil was less efficient in controlling mycelia
and growth was observed even following exposure to 4.0 mU/
l. However, the thyme essential oil was fungitoxic to spores
(MIC = 3.0 mU/l). In another set of trials the efficacy of the
oils and two of their constituents (carvacrol and thymol) in
controlling the natural microflora of surface-sterilized wheat
grain was studied. Juliano et al.3 demonstrated that thyme
oils possessed microbicidal activities, especially against
Gram-positive bacteria (MIC range 0.125—0.500 mg/ml)
and fungi (MIC 0.125—0.500 mg/ml). Soliman and Badeaa4
reported complete inhibition of Aspergillus flavus, Aspergil-
lus parasiticus, and Aspergillus ochraceus by the oils of
thyme and cinnamon (<500 ppm), marigold (<2000 ppm),
spearmint, basil, and quyssum (3000 ppm). There is a strong
correlation between the contents of camphor, thujones and
camphene, and the oils’ toxicity. The spring extract was the
least toxic (LD50: 1200 mg/kg body weight) and contained
lower levels of camphor (7.7%), a,b-thujone (1.3%), and
camphene (3.1%). Thus, we recommend that oil extracts
of sagemarketed for use in certain unconventional medicines
be prepared from spring plants (Farhat et al.5). Owing to
strong antibacterial and excellent protective features exhib-
ited in antioxidant activity tests, the essential oil andextracts from the herbal parts of Thymus eigii were sug-
gested for consideration as a natural source that can be freely
used in the food industry as a culinary herb (Tepe et al.6).
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doi:10.1016/j.ijid.2006.08.004Cryptococcal meningitis with raised intracra-
nial pressuremasquerading asmalignant hyper-
tension
A 39-year old man had recently been diagnosed with hyper-
tension and was taking nifedipine SR. He presented with neck
pain and diffuse headache of one week’s duration, and had
blurred vision for two days; he was afebrile. His blood
pressure (BP) was 189/118 mmHg and retinal flame-shaped
hemorrhages were seen without other abnormalities. An
electrocardiogram and plain computerized tomography brain
scan were normal. His blood pressure was controlled and the
headache improved with hypotensive agents. Routine blood
tests and screening for causes of secondary hypertension
were normal or negative.
Three weeks later he developed confusion and diplopia.
Examination revealed nuchal rigidity with Glasgow comascale 13 (M5E4V4), impaired abduction of both eyes, slug-
gish left pupil, papilloedema, and flame-shaped hemor-
rhages. His BP was 199/118 mmHg. A magnetic resonance
imaging brain scan with gadolinium was normal. Lumbar
puncture showed an opening pressure of 52 cmH2O. Cere-
brospinal fluid (CSF) protein was 2.3 g/l, glucose was
2.2 mmol/l (blood 6.8), and cell count was 87  106/l
(88% lymphocytes); the CSF was positive for Cryptococcus
neoformans on microscopy with elevated cryptococcal
antigen (1:32). Amphotericin and flucytosine were started
and ventriculostomy performed for continuous intracranial
pressure (ICP) monitoring. The lowering of his BP to 138/
90 mmHg with nifedipine SR was followed by deteriorated
consciousness and confusion, which improved when his BP
surged up again. Transcranial Doppler performed during
normal BP revealed reduced flow velocities over the major
intracranial arteries, which rose to normal when his BP
surged up to 185/103 mmHg. His mental state, ICP, and BP
